KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Equity Ratio (2016 - 2025)

NovoCure (NVCR) has disclosed Equity Ratio for 12 consecutive years, with 0.42 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 45.82% to 0.42 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42 through Dec 2025, up 45.82% year-over-year, with the annual reading at 0.42 for FY2025, 45.82% up from the prior year.
  • Equity Ratio hit 0.42 in Q4 2025 for NovoCure, up from 0.25 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.42 in Q4 2025 to a low of 0.25 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.34 across 5 years, with a median of 0.35 in 2023.
  • Biggest five-year swings in Equity Ratio: plummeted 48.23% in 2021 and later surged 45.82% in 2025.
  • Year by year, Equity Ratio stood at 0.36 in 2021, then grew by 2.77% to 0.37 in 2022, then dropped by 14.57% to 0.32 in 2023, then fell by 8.22% to 0.29 in 2024, then soared by 45.82% to 0.42 in 2025.
  • Business Quant data shows Equity Ratio for NVCR at 0.42 in Q4 2025, 0.25 in Q3 2025, and 0.28 in Q2 2025.